NVE Corp: Form 10-Q for the period ended Dec 31, 2014
Filed with the SEC on Jan 21, 2015 and accepted by EDGAR at Jan 21, 2015, 21:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $6.3m | us-gaap:Revenues |
| Revenue | 9 months2014-04-01 to 2014-12-31 | $23.0m | us-gaap:Revenues |
| Cost of revenue | 3 months2014-10-01 to 2014-12-31 | $1.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2014-04-01 to 2014-12-31 | $4.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $4.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2014-04-01 to 2014-12-31 | $18.4m | us-gaap:GrossProfit |
| Research and development | 3 months2014-10-01 to 2014-12-31 | $694.8k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2014-04-01 to 2014-12-31 | $2.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-10-01 to 2014-12-31 | $533.7k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2014-04-01 to 2014-12-31 | $1.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-10-01 to 2014-12-31 | $3.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-04-01 to 2014-12-31 | $14.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-10-01 to 2014-12-31 | $1.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-04-01 to 2014-12-31 | $5.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | $2.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-04-01 to 2014-12-31 | $10.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | $0.57 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-04-01 to 2014-12-31 | $2.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | $0.57 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-04-01 to 2014-12-31 | $2.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-10-01 to 2014-12-31 | 4,876,074 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-04-01 to 2014-12-31 | 4,871,270 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-04-01 to 2014-12-31 | $10.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2014-04-01 to 2014-12-31 | $114.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2014-04-01 to 2014-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-12-31 | $11.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $30.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $115.8m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $1.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-12-31 | $114.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000724910-15-000006. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.